Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade

被引：0
|
作者：
Wei, Spencer [1 ]
Levine, Jacob [2 ]
Cogdill, Alexandria [1 ]
Zhao, Yang [1 ]
Anang, Nana-Ama [1 ]
Andrews, Miles [1 ]
Sharma, Padmanee [1 ]
Wang, Jing [1 ]
Wargo, Jennifer [1 ]
Pe'er, Dana [2 ]
Allison, James [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Sloan Kettering Inst, New York, NY USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P379
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
    Wei, Spencer C.
    Levine, Jacob H.
    Cogdill, Alexandria P.
    Zhao, Yang
    Anang, Nana-Ama A. S.
    Andrews, Miles C.
    Sharma, Padmanee
    Wang, Jing
    Wargo, Jennifer A.
    Pe'er, Dana
    Allison, James P.
    CELL, 2017, 170 (06) : 1120 - 1133
  • [2] Distinct cellular mechanisms mediate anti-CTLA-4 and anti-PD-1 checkpoint blockade
    Wei, Spencer C.
    Levine, Jacob H.
    Pe'er, Dana
    Allison, James P.
    CANCER RESEARCH, 2017, 77
  • [3] Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
    Wei, Spencer C.
    Anang, Nana-Ama A. S.
    Sharma, Roshan
    Andrews, Miles C.
    Reuben, Alexandre
    Levine, Jacob H.
    Cogdill, Alexandria P.
    Mancuso, James J.
    Wargo, Jennifer A.
    Pe'er, Dana
    Allison, James P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (45) : 22699 - 22709
  • [4] Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
    Willsmore, Zena N.
    Coumbe, Ben G. T.
    Crescioli, Silvia
    Reci, Sara
    Gupta, Ayushi
    Harris, Robert J.
    Chenoweth, Alicia
    Chauhan, Jitesh
    Bax, Heather J.
    McCraw, Alexa
    Cheung, Anthony
    Osborn, Gabriel
    Hoffmann, Ricarda M.
    Nakamura, Mano
    Laddach, Roman
    Geh, Jenny L. C.
    MacKenzie-Ross, Alastair
    Healy, Ciaran
    Tsoka, Sophia
    Spicer, James F.
    Josephs, Debra H.
    Papa, Sophie
    Lacy, Katie E.
    Karagiannis, Sophia N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (03) : 544 - 556
  • [5] Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
    Hassel, Jessica C.
    Heinzerling, Lucie
    Aberle, Jens
    Baehr, Oliver
    Eigentler, Thomas K.
    Grimm, Marc-Oliver
    Gruenwald, Victor
    Leipe, Jan
    Reinmuth, Niels
    Tietze, Julia K.
    Trojan, Joerg
    Zimmer, Lisa
    Gutzmer, Ralf
    CANCER TREATMENT REVIEWS, 2017, 57 : 36 - 49
  • [6] Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma
    Kaehler, Katharina C.
    Hassel, Jessica C.
    Heinzerling, Lucie
    Loquai, Carmen
    Moessner, Rotraut
    Ugurel, Selma
    Zimmer, Lisa
    Gutzmer, Ralf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (07): : 662 - 681
  • [7] Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma
    Sandip P. Patel
    Eleanor Cano-Linson
    Young Kwang Chae
    Shiruyeh Schokrpur
    Christopher D. Lao
    Benjamin C. Powers
    Adrienne I. Victor
    Adedayo A. Onitilo
    Sarah Shin
    Naoko Takebe
    Sara Threlkel
    Christine M. McLeod
    Helen X. Chen
    Elad Sharon
    Megan Othus
    Christopher W. Ryan
    Charles D. Blanke
    Razelle Kurzrock
    npj Precision Oncology, 9 (1)
  • [8] Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
    Seidel, Judith A.
    Otsuka, Atsushi
    Kabashima, Kenji
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [9] Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
    Gide, Tuba N.
    Quek, Camelia
    Menzies, Alexander M.
    Tasker, Annie T.
    Shang, Ping
    Holst, Jeff
    Madore, Jason
    Lim, Su Yin
    Velickovic, Rebecca
    Wongchenko, Matthew
    Yan, Yibing
    Lo, Serigne
    Carlino, Matteo S.
    Guminski, Alexander
    Saw, Robyn P. M.
    Pang, Angel
    McGuire, Helen M.
    Palendira, Umaimainthan
    Thompson, John F.
    Rizos, Helen
    da Silva, Ines Pires
    Batten, Marcel
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    CANCER CELL, 2019, 35 (02) : 238 - +
  • [10] Combination Therapy with Anti-CTLA-4 and Anti-PD-1 Leads to Distinct Immunologic Changes In Vivo
    Das, Rituparna
    Verma, Rakesh
    Sznol, Mario
    Boddupalli, Chandra Sekhar
    Gettinger, Scott N.
    Kluger, Harriet
    Callahan, Margaret
    Wolchok, Jedd D.
    Halaban, Ruth
    Dhodapkar, Madhav V.
    Dhodapkar, Kavita M.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (03): : 950 - 959
12345